Literature DB >> 11748245

Activation of smooth muscle myosin light chain kinase by calmodulin. Role of LYS(30) and GLY(40).

Jacquelyn E Van Lierop1, David P Wilson, Jonathan P Davis, Svetlana Tikunova, Cindy Sutherland, Michael P Walsh, J David Johnson.   

Abstract

Calmodulin (CaM)-dependent myosin light chain kinase (MLCK) plays a key role in activation of smooth muscle contraction. A soybean isoform of CaM, SCaM-4 (77% identical to human CaM) fails to activate MLCK, whereas SCaM-1 (90.5% identical to human CaM) is as effective as CaM. We exploited this difference to gain insights into the structural requirements in CaM for activation of MLCK. A chimera (domain I of SCaM-4 and domains II-IV of SCaM-1) behaved like SCaM4, and analysis of site-specific mutants of SCaM-1 indicated that K30E and G40D mutations were responsible for the reduction in activation of MLCK. Competition experiments showed that SCaM-4 binds to the CaM-binding site of MLCK with high affinity. Replacement of CaM in skinned smooth muscle by exogenous CaM or SCaM-1, but not SCaM-4, restored Ca(2+)-dependent contraction. K30E/M36I/G40D SCaM-1 was a poor activator of contraction, but site-specific mutants, K30E, M36I and G40D, each restored Ca(2+)-induced contraction to CaM-depleted skinned smooth muscle, consistent with their capacity to activate MLCK. Interpretation of these results in light of the high-resolution structures of (Ca(2+))(4)-CaM, free and complexed with the CaM-binding domain of MLCK, indicates that a surface domain containing Lys(30) and Gly(40) and residues from the C-terminal domain is created upon binding to MLCK, formation of which is required for activation of MLCK. Interactions between this activation domain and a region of MLCK distinct from the known CaM-binding domain are required for removal of the autoinhibitory domain from the active site, i.e., activation of MLCK, or this domain may be required to stabilize the conformation of (Ca(2+))(4)-CaM necessary for MLCK activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11748245     DOI: 10.1074/jbc.M111404200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Designing proteins to combat disease: Cardiac troponin C as an example.

Authors:  Jonathan P Davis; Vikram Shettigar; Svetlana B Tikunova; Sean C Little; Bin Liu; Jalal K Siddiqui; Paul M L Janssen; Mark T Ziolo; Shane D Walton
Journal:  Arch Biochem Biophys       Date:  2016-02-18       Impact factor: 4.013

Review 2.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 3.  Recent advances in bioelectronics chemistry.

Authors:  Yin Fang; Lingyuan Meng; Aleksander Prominski; Erik N Schaumann; Matthew Seebald; Bozhi Tian
Journal:  Chem Soc Rev       Date:  2020-07-16       Impact factor: 54.564

4.  Calmodulin-Calcineurin Interaction beyond the Calmodulin-Binding Region Contributes to Calcineurin Activation.

Authors:  Bin Sun; Darin Vaughan; Svetlana Tikunova; Trevor P Creamer; Jonathan P Davis; P M Kekenes-Huskey
Journal:  Biochemistry       Date:  2019-09-19       Impact factor: 3.162

5.  Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance.

Authors:  Lei-Miao Yin; Yu-Dong Xu; Ling-Ling Peng; Ting-Ting Duan; Jia-Yuan Liu; Zhijian Xu; Wen-Qian Wang; Nan Guan; Xiao-Jie Han; Hai-Yan Li; Yu Pang; Yu Wang; Zhaoqiang Chen; Weiliang Zhu; Linhong Deng; Ying-Li Wu; Guang-Bo Ge; Shuang Huang; Luis Ulloa; Yong-Qing Yang
Journal:  Sci Transl Med       Date:  2018-02-07       Impact factor: 17.956

6.  The CaMKII inhibitor KN93-calmodulin interaction and implications for calmodulin tuning of NaV1.5 and RyR2 function.

Authors:  Christopher N Johnson; Rekha Pattanayek; Franck Potet; Robyn T Rebbeck; Daniel J Blackwell; Roman Nikolaienko; Vasco Sequeira; Remy Le Meur; Przemysław B Radwański; Jonathan P Davis; Aleksey V Zima; Razvan L Cornea; Steven M Damo; Sandor Györke; Alfred L George; Björn C Knollmann
Journal:  Cell Calcium       Date:  2019-07-30       Impact factor: 6.817

7.  Comparing the calcium binding abilities of two soybean calmodulins: towards understanding the divergent nature of plant calmodulins.

Authors:  Jessica L Gifford; Mostafa Jamshidiha; Jeffrey Mo; Hiroaki Ishida; Hans J Vogel
Journal:  Plant Cell       Date:  2013-11-19       Impact factor: 11.277

8.  The solution structure of a plant calmodulin and the CaM-binding domain of the vacuolar calcium-ATPase BCA1 reveals a new binding and activation mechanism.

Authors:  Hiroaki Ishida; Hans J Vogel
Journal:  J Biol Chem       Date:  2010-09-29       Impact factor: 5.157

9.  Calmodulin has the Potential to Function as a Ca-Dependent Adaptor Protein.

Authors:  Aaron P Yamniuk; Mario Rainaldi; Hans J Vogel
Journal:  Plant Signal Behav       Date:  2007-09

Review 10.  Redox regulation of the actin cytoskeleton and its role in the vascular system.

Authors:  Qian Xu; Lauren P Huff; Masakazu Fujii; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2017-03-08       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.